CAS 654080-03-2

Propanedioic acid,[5-[[6-[5-(1,1-dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]-,disodium salt

Description:

Propanedioic acid, specifically the compound with the name "5-[[6-[5-(1,1-dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]-, disodium salt" (CAS number 654080-03-2), is a synthetic organic compound characterized by its complex structure, which includes a propanedioic acid backbone and various aromatic and aliphatic substituents. This compound features a disodium salt form, indicating the presence of two sodium ions that enhance its solubility in aqueous environments. The presence of the benzoxazole and naphthalene moieties suggests potential applications in pharmaceuticals or as a dye, owing to their conjugated systems that can exhibit interesting electronic properties. Additionally, the bulky tert-butyl group may influence the compound's steric properties and stability. The overall structure implies potential interactions with biological systems, making it a candidate for further research in medicinal chemistry or materials science. However, specific properties such as melting point, solubility, and reactivity would require empirical data for precise characterization.

Formula: C₂₉H₃₁NO₆・2Na

2-[5-[[6-[5-(1,1-Dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]propanedioicaciddisodiumsalt

CAS: 654080-03-2

Formula: C₂₉H₂₉NNa₂O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 533.5232

Ref: IN-DA01ENIK

SK-216

CAS: 654080-03-2

SK-216

Purity: ≥98%

Molecular weight: 535.55g/mol

Ref: 54-BUP22158

SK-216

Controlled Product

CAS: 654080-03-2

Applications SK-216 is a plasminogen activator inhibitor-1 (PAI-1) that limits tumor progression and angiogenesis, a therapeutic target in the management of malignancy.
References Masuda, T., et al.: Mol. Cancer Ther., 12, 2378 (2013)

Formula: C₂₉H₂₉NNa₂O₆

Color and Shape: Neat

Molecular weight: 533.52

Ref: TR-S550025

SK-216

CAS: 654080-03-2

SK-216 is a drug that inhibits the synthesis of messenger RNA and suppresses angiogenesis. This drug has been shown to reduce the number of blood vessels in lung fibroblasts and subcutaneous tumors in mice, as well as inhibit the proliferation of cancer cells. SK-216 also stimulates lipoprotein lipase activity in wild-type mice and blocks angiogenesis by inhibiting the production of angiogenic factors such as VEGF and TGF-β1. SK-216 is currently being studied for its potential use in the treatment of pleural mesothelioma, urokinase-type plasminogen activator (uPA) receptor positive epithelial mesenchymal cells.

Formula: C₂₉H₂₉NNa₂O₆

Purity: Min. 95%

Molecular weight: 533.5 g/mol

Ref: 3D-EBB08003

SK-216

CAS: 654080-03-2

SK-216,PAI-1 inhibitor. Reduces tumor angiogenesis. Inhibits VEGF-induced endothelial cell migration. Alleviates pulmonary fibrosis.

Formula: C₂₉H₂₉NNa₂O₆

Purity: 98.29%

Color and Shape: Solid

Molecular weight: 533.52

Ref: TM-T28788